U.S. flag An official website of the United States government
  1. Home
  2. About FDA
  3. FDA Organization
  4. Oncology Center of Excellence
  5. Project Community
  1. Oncology Center of Excellence

Project Community

FDA Oncology Center of Excellence Project Community: Empowering Patients Living with Cancer, Survivors, Advocates and Consumers

image-1

Welcome to the FDA Oncology Center of Excellence (OCE) Project Community webpage! Our focus is to empower patients living with cancer, survivors, advocates, and consumers. This page features news and information about OCE’s Project Community and related external outreach updates.

 

What is Project Community?

Project Community is a national public health initiative established by the FDA Oncology Center of Excellence to introduce the work of FDA oncologists (cancer doctors) and hematologists (blood disease specialists) to people living in communities across the nation and “beyond the beltway”.

Our primary audience includes patients living with cancer, survivors, advocates and families, especially people living in underserved or under-represented urban and rural communities who are at greater cancer risk.

Project Community’s main objectives:

  • Increasing minority participation in clinical trials
  • Increasing knowledge and minority participation in genetic databases

To encourage healthy people and patients seeking an opportunity to help advance cancer research, Project Community produced a 3-minute video.

 

What is Precision Medicine?

 


 

 

Meet the Team

Rea Blakey

Rea Blakey
Associate Director for External Outreach and Engagement,
Oncology Center of Excellence,
US Food and Drug Administration

Rea Blakey serves as a liaison leader for patients, advocacy groups, cancer community organizations and others interested in influencing oncology-related medical product regulatory decision-making. Rea leads OCE’s Project Community external outreach and engagement initiative which encompasses all interested cancer community stakeholders as well as focusing on increasing minority and under-represented population awareness and participation in cancer clinical trials.

 

In conjunction with her role as AD of External Outreach and Engagement at OCE, Ms. Blakey is honored to be included as an author on “Disparities in Cancer Prevention in the COVID-19 Era” published in the American Association for Cancer Research journal Cancer Research Prevention. Since she joined the Immediate Office of the FDA OCE in July 2018, Rea’s been responsible for managing unique, far-reaching, and sometimes previously unresolved issues relating to outreach and engagement by granting stakeholders a myriad of opportunities to provide input to OCE. Ms. Blakey held a similar role as Engagement Team Lead under the FDA Center Director’s Office for Drug Evaluation and Research (CDER).

Before coming to FDA, Rea’s career centered on TV dissemination of public health information. She reported on air as a CNN Medical Correspondent, hosted medical programs at Discovery Channel, and worked 13+ years as a News Anchor and Health Reporter at Washington, DC’s WJLA-TV winning two Emmy Awards. Ms. Blakey was also once the Director of Communication at GW Medical Faculty Associates in Washington, DC.

Stowe Ginneh

Ginneh Stowe is a Senior Regulatory Project Manager on the Oncology Program Management Team in the Oncology Center of Excellence (OCE). She works in collaboration with OCE leadership to provide essential information related to regulatory issues and medical products to external stakeholders in the oncology community. She earned her undergraduate degree from Hampton University and a Master of Science degree from Georgetown University. She is also alumni of a W.K. Kellogg Fellowship at the University of North Carolina Kenan-Flagler Business School, earned a Master’s Certificate in Project Management from The George Washington University, and is a certified Six Sigma Green Belt. She has a proven record in health communication, public health, and healthcare policy and management.

Connect With Us!

Twitter: #OCEProjectCommunityExternal Link Disclaimer
Email: OCE-Engagement@fda.hhs.gov

Download & Print Project Community “Cancer Q & A” Brochures:

Multiple Myeloma two-pager (349KB PDF)

Multiple Myeloma trifold brochure (3.21MB PDF)

Alternatives to Using Placebos in Cancer Clinical Trials (1.5MB PDF)

What is Precision Oncology? (2.6MB PDF)

FDA Resources for Patients Living with Cancer and Advocates

FDA offers many online resources for patients and consumers interested in learning more about cancer clinical trials. Several informative pages are also available through the FDA Office of Minority Health and Health Equity links under Cancer.

Clinical Trials

National Cancer Institute (NCI) Resources

Taking Part in Cancer Research Studies

Donating Your Blood, Tissue and Other Samples

Learn About Cancer Prevention Clinical Trials

Does Your Community Organization Work with Cancer Researchers?

Certain groups working in cancer health equity and special populations are encouraged to explore OCE Scientific Interest Areas in the FDA Broad Agency Announcement . They include, but aren’t limited to:

  • Historically Black Colleges and Universities (HBCU),
  • Minority Institutions (MI),
  • Small Business concerns,
  • Small Disadvantaged Business concerns,
  • Women-Owned Small Business concerns,
  • Veteran-Owned Small Business concerns,
  • Service-Disabled Veteran-Owned Small Business concerns,
  • and HUB Zone Small Business concerns

If your cancer research organization is interested, see OCE’s Scientific Collaborative opportunities.

Additional Information:

Connect With Us!

Twitter: #OCEProjectCommunity
Email: OCE-Engagement@fda.hhs.gov

 

Do you have a Patient Inquiry for FDA?

Patients: Ask FDA

Request to Connect Logo
Back to Top